Infections related to central venous catheters in US intensive-care units [4]

Lancet

Volumn 361, Issue 9368, 2003, Pages 1562-

  Mermel, Leonard ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL VENOUS CATHETER; COST OF ILLNESS; DEVICE INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE; LETTER; PREVALENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; CENTRAL VENOUS CATHETERIZATION; INTENSIVE CARE UNIT; NOTE; SEPSIS; STATISTICS; UNITED STATES;

CATHETERIZATION, CENTRAL VENOUS; HUMANS; INTENSIVE CARE UNITS; PREVALENCE; SEPSIS; UNITED STATES;

EID: 0242526966     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13198-4     Document Type: Letter

References (5)

1. Lyte M., Freestone P.P.E., Neal C.P., et al. Stimulation of Staphylococus epidermidis growth and biofilm formation by catecholamine inotropes. Lancet. 361:2003;130-135.
2. Mermel L.A. Prevention of intravascular catheter-related infections. Ann Intern Med. 132:2000;391-402.
3. Mermel L.A. Correction on prevention of intravascular catheter-related infections. Ann Intern Med. 133:2000;395.
4. Pratt R.J., Pellowe C., Loveday H.P., et al. Guidelines for preventing infections associated with the insertion and maintenance of central venous catheters. J Hosp Infect. 47:2001;S47-S67.
5. O'Grady N.P., Alexander M., Dellinger E.P., et al. Guidelines for the prevention of intravascular catheter-related infection. Morb Mortal Wkly Rep. 51:(RR 10):2002;1-29.